Welcome to our dedicated page for SOLITRON DEVICES SEC filings (Ticker: SODI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SOLITRON DEVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SOLITRON DEVICES's regulatory disclosures and financial reporting.
Olesen Value Fund L.P., a more than ten percent holder of Solitron Devices Inc. (SODI), reported open-market sales of common stock on July 8 and July 10 at prices of $26.85 and $26.54 per share, respectively. After these transactions, the Reporting Persons collectively report 222,931 shares of common stock, with ownership held directly by the fund and indirectly through related entities, each disclaiming beneficial ownership beyond its pecuniary interest.
Olesen Value Fund L.P., a ten percent owner of Solitron Devices Inc, reported a series of open-market sales of common stock. Across July 1–7, 2026, entities associated with the fund sold a total of 13,488 shares at prices ranging from $26.24 to $26.83 per share.
Following these transactions, the reporting group shows 226,298 shares of Solitron Devices common stock beneficially owned. The shares are held directly by Olesen Value Fund L.P. and indirectly through related entities and Christian Olesen, each of whom disclaims beneficial ownership beyond their pecuniary interest.
Olesen Value Fund L.P. and related entities reported open-market sales of Solitron Devices Inc. common stock, totaling 27,352 shares, in late June 2026. The sales were executed at prices around $26.59–$26.60 per share.
After these transactions, the filing shows combined holdings of 229,670 shares of Solitron Devices common stock. Footnotes state that Olesen Value Fund L.P., its general partner, its investment manager, and Christian Olesen are joint reporting persons and each disclaims beneficial ownership except to the extent of any pecuniary interest.
SODI proposed the sale of 20,000 shares of Common Stock, $0.01 par value, via a Section 144 notice dated 06/24/2026. The shares are listed OTC-PINK and were acquired in open-market purchases beginning 10/16/2015 with cash settlement beginning 10/22/2015.
The filing names Auerbach Grayson & Company LLC as the broker and records payment as "cash payment of good funds upon regular trade settlement". The notice describes planned resale method as open-market transactions; timing and proceeds recipients are not detailed in the excerpt.
SOLITRON DEVICES INC director and CEO Howard Timothy Eriksen reported an internal restructuring of his Solitron share holdings. On June 5, 2026, 5,787 shares of common stock were moved from an indirect entity to his direct ownership at a reported price of $0.00 per share, with no open-market buying or selling.
Following these transactions, Eriksen directly holds 60,827 shares of common stock and is also reported as indirectly associated with 264,396 shares held through investment entities and managed accounts. Footnotes state that he may be deemed to beneficially own these indirect holdings but disclaims beneficial ownership beyond his pecuniary interest.
Solitron Devices, Inc. reports higher full-year results for the fiscal year ended February 28, 2026, driven by strong defense and aerospace demand. Net sales rose about 21% to $16.97 million from $14.05 million, lifting gross profit to $5.12 million and margin to 30%.
Backlog expanded sharply to $27.28 million, about 51% above the prior year, supported by a significant AMRAAM program order and a book-to-bill ratio of roughly 1.54 to 1. Despite higher operating income, net income was essentially flat at $0.81 million due to contingent consideration tied to the Micro Engineering Inc. acquisition and investment mark-to-market losses.
The business remains highly concentrated, with ConMed Linvatec and RTX Corporation representing 33% and 27% of 2026 net sales, and nine customers providing 91% of revenue. Cash and equivalents were $3.91 million at year-end, with working capital of $9.03 million, and management believes existing liquidity is sufficient for at least the next twelve months.
Solitron Devices, Inc. held its Annual Meeting of Stockholders on April 24, 2026. Stockholders elected Charles M. Gillman as Class III director until the 2028 annual meeting, with 1,049,702 votes for, 60,102 against, 19,127 abstentions and 615,787 broker non-votes.
Stockholders ratified Whitley Penn LLP as independent registered public accountants for the fiscal year ending February 28, 2026, with 1,743,196 votes for, 1,106 against and 416 abstentions. They also approved, on a non-binding basis, the Company’s Say on Pay proposal, with 1,104,814 votes for, 1,766 against, 22,351 abstentions and 615,787 broker non-votes. With proposals 1, 2 and 3 approved, proposal 4 was moot.
Solitron Devices, Inc. reported preliminary, unaudited results for its fiscal 2026 fourth quarter ended February 28, 2026. Revenue is expected to be approximately $5.3 million, with gross profit between $2.1 million and $2.2 million and operating income between $1.3 million and $1.4 million.
The company expects a one-time non-operating charge of about $0.3 million to $0.4 million from higher contingent consideration tied to increased backlog at its MEI acquisition, leading to pre-tax income of $0.9 million to $1.0 million. Bookings declined versus the prior-year quarter, partly due to timing of AMRAAM orders, but management remains encouraged about potential multi-year defense orders.
The board’s previously announced review of strategic alternatives—including a possible sale, acquisition, or return of capital—remains ongoing, with a data room available to interested parties under non-disclosure agreements.
Solitron Devices President and COO Mark Matson reported a Form 4 transaction involving 5,000 shares of common stock. Under his employment agreement, he may purchase up to 5,000 shares each quarter at the quarter’s weighted average price, which was $21.22 for the fourth quarter of fiscal 2026, compared with a $24.50 share price on the exercise date. After this transaction, he directly holds 238,573 shares.
Solitron Devices, Inc. calls its 2025 Annual Meeting of Stockholders for April 24, 2026 at its West Palm Beach, Florida headquarters. Holders of 2,147,703 common shares as of February 27, 2026 may vote in person or by proxy.
Stockholders will vote on re‑electing Charles M. Gillman as Class III director for a term running to the 2028 annual meeting, ratifying Whitley Penn LLP as independent accountants for the year ending February 28, 2026, and approving a non‑binding “Say on Pay” advisory resolution on named executive officer compensation. The proxy details the staggered five‑member board, committee structure and independence determinations, director and executive pay (including 2024 increases for directors and salary increases for key executives), major shareholdings, related‑party transactions and equity compensation plan capacity.
The document also discloses prior final regulatory orders involving Chairman David W. Pointer and director Charles M. Gillman, board risk oversight practices, the company’s code of ethics and insider trading and anti‑hedging policies, and explains how stockholders can submit future director nominations and proposals.